Summary & Overview
CPT 80322: Alcohol Biomarker Panel, Multi-Analyte
CPT code 80322 designates a laboratory assay that detects and quantifies three or more alcohol biomarker compounds in a patient specimen. Such multi-analyte alcohol biomarker testing is used to identify recent or ongoing alcohol exposure, support clinical diagnosis, monitor treatment or abstinence, and inform forensic or occupational evaluations. Nationally, standardized coding for multi-analyte alcohol biomarker panels enables clearer billing, clinical communication, and surveillance of alcohol-related testing patterns.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service settings, common modifiers and billing notes, and what typical coverage patterns and payer engagement look like for laboratory biomarker tests. The publication summarizes benchmarks where available, highlights billing and coding considerations for laboratories and clinicians, and outlines implications for clinical workflows and reporting. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes are noted as not provided.
Billing Code Overview
CPT code 80322 describes a laboratory service in which a lab analyst detects and measures alcohol biomarkers in a patient specimen. Alcohol biomarkers are physiological indicators of alcohol exposure or ingestion. This particular test covers analysis for three or more alcohol biomarker compounds, providing a multi-analyte assessment of alcohol use or recent exposure.
Service type: Clinical laboratory toxicology/biomarker testing
Typical site of service: Clinical laboratory or hospital laboratory, with specimens collected in outpatient clinics, physician offices, inpatient settings, or specialized testing centers.
Clinical & Coding Specifications
Clinical Context
A 38-year-old adult presents to an outpatient toxicology laboratory after referral from occupational health and a primary care provider who suspects recent alcohol exposure or heavy drinking. The provider orders an alcohol biomarker panel to detect and quantify multiple alcohol-related metabolites in a blood specimen to support occupational fitness-for-duty evaluation, treatment monitoring in an alcohol-use disorder program, or medico-legal confirmation of recent ingestion. The patient arrives at a clinical laboratory draw station; phlebotomy obtains a blood sample, which is accessioned and sent to the clinical chemistry/toxicology lab. The laboratory analyst performs multi-analyte testing for three or more alcohol biomarker compounds (for example, ethyl glucuronide, ethyl sulfate, phosphatidylethanol) using validated analytical methods, documents results in the laboratory information system, and issues a report to the ordering clinician. Typical sites of service include outpatient clinical laboratories, hospital laboratory departments, and specialized toxicology reference labs. Results inform clinical management, occupational decisions, or program compliance monitoring and are interpreted alongside clinical history and other testing (e.g., breathalyzer, serum ethanol).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component of the test separate from technical services. |